Who are Arcutis Biotherapeutics, Inc.'s main suppliers?

Arcutis Biotherapeutics, Inc. (ARQT) key suppliers include: THIRD-PARTIES, SLR Investment Corp.. View the full supplier network at chainsifter.com/chain/ARQT.

Who are Arcutis Biotherapeutics, Inc.'s major customers?

Arcutis Biotherapeutics, Inc. (ARQT) key customers include: SLR Investment Corp., SLR Investment Corp.. View the full customer network at chainsifter.com/chain/ARQT.

What sector is Arcutis Biotherapeutics, Inc. in?

Arcutis Biotherapeutics, Inc. (ARQT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Arcutis Biotherapeutics, Inc. (ARQT): 6 Verified Supply Chain Relationships

2Suppliers

2Customers

2Debt Items

7Related Chains

Source-Backed Evidence Depth

Arcutis Biotherapeutics, Inc. (ARQT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

2Distinct source URLs

4High confidence

0.823Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Arcutis Biotherapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
THIRD-PARTIES	THIRD-PARTIES	90%	We rely on third parties to conduct our nonclinical studies and clinical trials, as well as for the manufacturing and supply of our product candidates and for the commercial supply of our products.
SLRC	SLR Investment Corp.	72%	Reciprocal relationship from SLRC graph: Reciprocal relationship from ARQT graph: Reciprocal relationship from SLRC graph: Reciprocal relationship from ARQT graph: Reciprocal relationship from SLRC g…

Arcutis Biotherapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
SLRC	SLR Investment Corp.	72%	Reciprocal relationship from SLRC graph: Reciprocal relationship from ARQT graph: Reciprocal relationship from SLRC graph: Reciprocal relationship from ARQT graph: Reciprocal relationship from SLRC g…
SLRC	SLR Investment Corp.	72%	n increase in sales and marketing expenses of $5.9 million and an increase in compensation and employee benefit related expenses of $4.4 million. These increases were primarily due to our continued c…

Arcutis Biotherapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ARQT-DEBT	Debt stack $108.9M	90%	Market cache reports total debt of $108.9M.
ARQT-DEBT-7854	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.

Arcutis Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Arcutis Biotherapeutics, Inc..

Arcutis Biotherapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
ARQT-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 272 tracked holders.

Arcutis Biotherapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SLRC	SLR Investment Corp.	100.00	1	['customer', 'supplier']
ARDX	Ardelyx, Inc.	100.00	2
STIM	Neuronetics, Inc.	100.00	2
GSL	Global Ship Lease, Inc.	50.00	2
RZLT	Rezolute, Inc.	50.00	2
TMCI	Treace Medical Concepts, Inc.	14.78	2
OM	Outset Medical, Inc.	14.78	2

Arcutis Biotherapeutics, Inc. Supply Chain